O. Hoshino et al. / Tetrahedron 57 (2001) 265±271
269
followed by removal of the solvent gave a solid, which was
puri®ed by recrystallization.
(8a). 7a (100 mg, 0.24 mmol), Pb(OAc)4 (127 mg,
0.29 mmol), and CH2Cl2 (1 mL) were used: 8a (oil); IR n:
1740, 1680 cm21; 1H NMR d: 2.05, 2.08 (3H, each s), 3.28,
3.40 (3H, each s), 3.84 (6H, s), 4.92±5.18 (1H, m), 5.60±
5.74, 5.86±6.07 (each 1H, m), 6.52±6.84 (3H, m).
3.2.1. N-Tri¯uoroacetyl-1-(3,4-dimethoxy)benzyl-1,2,3,4-
tetrahydro-7-methoxyisoquinolin-6-ol (7a). 6a (1.02 g,
2.0 mmol), 10% Pd±C (0.42 g), and AcOEt (50 mL) were
used: 7a (0.784 g, 93%), mp 148±1498C (benzene). Anal.
Calcd for C21H22NO5F3: C, 59.29; H, 5.21; N, 3.29; F, 13.40.
Found: C, 59.29; H, 5.19; N, 3.40; F, 13.46. MS m/z: 425
(M1); IR n: 3530, 1675 cm21; 1H NMR d: 3.68, 3.76, 3.83
(each 3H, s), 5.36±5.60 (2H, m), 6.20±6.84 (5H, m).
3.3.2. N-Formyl-1-(3,4-dimethoxy)benzyl-7-acetoxy-1,2,3,
4,6,7-hexahydro-7-methoxy-6-oxoisoquinoline (8b). 7b
(100 mg, 0.28 mmol), Pb(OAc)4 (149 mg, 0.34 mmol),
and CH2Cl2 1 (5 mL) were used: 8b (oil); IR n: 1740,
1670 cm21; H NMR d: 2.05, 2.08, 2.10 (3H, each s),
3.32, 3.40, 3.42 (3H, each s), 3.84 (6H, s), 5.00±5.32 (1H,
m), 5.60±6.04 (2H, m), 6.50±6.84 (3H, m), 7.69, 8.78, 8.12
(1H, each s).
3.2.2. N-Formyl-1-(3,4-dimethoxy)benzyl-1,2,3,4-tetra-
hydro-7-methoxyisoquinolin-6-ol (7b). 6b (1.3 g,
2.9 mmol), 10% Pd±C (0.62 g), and AcOEt (50 mL) were
used: 7b (0.9 g, 86%), mp 177±1798C (benzene). HRMS
m/z Calcd for C20H23NO5 (M1): 357.1574. Found: C,
3.3.3. N-Acetyl-1-(3,4-dimethoxy)benzyl-7-acetoxy-1,2,3,
4,6,7-hexahydro-7-methoxy-6-oxoisoquinoline (8c). 7c
(100 mg, 0.27 mmol), Pb(OAc)4 (143 mg, 0.32 mmol),
and CH2Cl2 (5 mL) were used: 8c (oil); IR n: 1740, 1685,
357.1552. MS m/z: 357 (M1); IR n: 3530, 1650 cm21; 1
H
NMR d: 3.66, 3.76, 3.84 (each 3H, s), 6.22±6.83 (5H, m),
7.66, 8.08 (1H, each s).
1640 cm21 1H NMR d: 2.02, 2.04, 2.08, 2.12, 2.14
;
(6H, each s), 3.20, 3.32 (3H, each s), 3.83, 3.85 (each
3H, s), 4.98±5.32 (1H, m), 5.48±6.02 (2H, m), 6.48±
6.88 (3H, m).
3.2.3. N-Acetyl-1-(3,4-dimethoxy)benzyl-1,2,3,4-tetra-
hydro-7-methoxyisoquinolin-6-ol (7c). 6c (1.06 g,
2.3 mmol), 10% Pd±C (0.42 g), and AcOEt (20 mL)-
CHCl3 (30 mL) were used: 7c (0.734 g, 86%), mp 141±
1428C (benzene±ether). Anal. Calcd for C21H25NO5: C,
67.91; H, 6.78; N, 3.77. Found: C, 67.81; H, 6.74; N, 3.84.
MS m/z: 371 (M1); IR n: 3530, 1620 cm21; 1H NMR d: 1.61,
2.12 (3H, each s), 3.60, 3.76, 3.83 (each 3H), 4.56±4.85 (1H,
m), 5.40±5.65 (2H, m), 6.09±6.88 (5H, m).
3.3.4. N-Ethoxycarbonyl-1-(3,4-dimethoxy)benzyl-7-acet-
oxy-1,2,3,4,6,7-hexahydro-7-methoxy-6-oxoisoquinoline
(8d). 7d (100 mg, 0.25 mmol), Pb(OAc)4 (133 mg,
0.30 mmol), and CH2Cl2 (5 mL) were used: 8d (oil); IR n:
1740, 1680 cm21 1H NMR d: 1.28, 1.29 (3H, each t,
;
J7.1 Hz), 2.08, 2.28 (3H, each s), 3.20, 3.38 (3H, each
s), 3.84 (6H, s), 5.44±5.68 (1H, m), 5.48±6.00 (2H, m),
6.48±6.92 (3H, m).
3.2.4. N-Ethoxycarbonyl-1-(3,4-dimethoxy)benzyl-1,2,3,4-
tetrahydro-7-methoxyisoquinolin-6-ol (7d). 6d (0.93 g,
1.9 mmol), 10% Pd±C (0.37 g), and AcOEt (50 mL) were
used: 7d (0.737 g, 99%), mp 80±958C (benzene). Anal.
Calcd for C22H27NO6´0.5H2O: C, 64.38; H, 6.88; N, 3.41.
Found: C, 64.24; H, 6.62; N, 3.51. MS m/z: 400 (M121); IR
3.3.5. N-Methanesulfonyl-1-(3,4-dimethoxy)benzyl-7-acet-
oxy-1,2,3,4,6,7-hexahydro-7-methoxy-6-oxoisoquinoline
(8e). 7e (100 mg, 0.25 mmol), Pb(OAc)4 (139 mg,
0.31 mmol), and CH2Cl2 (1 mL) were used: 8e (oil); IR n:
1740, 1680 cm21; 1H NMR d: 2.04, 2.08 (3H, each s), 2.60,
2.88 (3H, each s), 3.24, 3.40 (3H, each s), 3.84, 3.85 (each
3H, s), 4.48±4.86 (1H, m), 5.64, 5.72 (1H, each s), 5.84±
6.04 (1H, m), 6.56±6.84 (3H, m).
1
n: 3430, 1670 cm21; H NMR d: 1.15, 1.24 (3H, each t,
J7.1 Hz), 3.60, 3.69, 3.76, 3.78, 3.84 (9H, each s), 4.87±
5.28 (1H, m), 6.07±6.84 (5H, m).
3.2.5. N-Methanesulfonyl-1-(3,4-dimethoxy)benzyl-1,2,3,4-
tetrahydro-7-methoxyisoquinolin-6-ol (7e). 6e (0.91 g,
1.8 mmol), 10% Pd±C (0.39 g), and AcOEt (50 mL) were
used: 7e (0.59 g, 84%), mp 170±1718C (benzene). Anal.
Calcd for C20H25NO6S: C, 58.95; H, 6.18; N, 3.44; S,
7.87. Found: C, 59.10; H, 6.18; N, 3.60; S, 7.87. MS m/z:
3.4. A general procedure for the reaction of o-QAs (8)
with AcOH
A solution of o-QA (8) [prepared from 7] in AcOH was
stirred at 30±408C for 2±3 h. The reaction mixture was
diluted with water and basi®ed with 10% aq. Na2CO3
solution. The product was taken up in CH2Cl2. A residue
obtained on usual work-up of the organic layer was
puri®ed by preparative TLC (developing solvent:
AcOEt:hexane2:1) or recrystallization.
1
407 (M1); IR n: 3530, 1310, 1140 cm21; H NMR d: 2.49
(3H, s), 3.70, 3.81, 3.84 (each 3H, s), 5.94 (1H, t, J7.1 Hz),
6.21±6.82 (5H, m).
3.3. A general procedure for formation of N-acyl- and
N-methanesulfonyl-1-(3,4-dimethoxy)benzyl-6-acetoxy-
1,2,3,4,6,7-hexahydro-7-methoxy-6-oxoisoquinolines (8)
(o-quinol acetates)
3.4.1. N-Tri¯uoroacetyl-1-(3,4-dimethoxy)benzyl-8a-acet-
oxy-1,2,3,4,6,8a-hexahydro-7-methoxy-6-oxoisoquino-
line (9a). 8a [prepared from 7a (100 mg)] and AcOH
(10 mL) were used (reaction time: 3 h): 9a (87 mg, 77%),
mp 165±1678C (EtOH). Anal. Calcd for C23H24F3NO7:
C, 57.14; H, 5.00; N, 2.90; F, 11.79. Found: C, 57.19;
H, 5.08; N, 3.09; F, 11.89. MS m/z: 483 (M1); IR n:
The reaction of 7 with Pb(OAc)4 in CH2Cl2 was carried out
in a manner reported previously3a (reaction time: 0.5 h) to
produce quantitatively o-quinol acetates (8), which were
used in the next reaction without further puri®cation.
1
1745, 1675, 1650, 1625 cm21; H NMR d: 2.01 (3H, s),
3.3.1. N-Tri¯uoroacetyl-1-(3,4-dimethoxy)benzyl-7-acet-
oxy-1,2,3,4,6,7-hexahydro-7-methoxy-6-oxoisoquinoline
3.26, 3.52 (3H, each s), 3.84 (6H, s), 5.58 (1H, s),
6.08±6.36 (4H, m).